Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

CD9 Expression in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Lobular Carcinoma.

Baek J, Jang N, Choi JE, Kim JR, Bae YK.

J Breast Cancer. 2019 Feb 1;22(1):77-85. doi: 10.4048/jbc.2019.22.e9. eCollection 2019 Mar.

2.

Prognostic significance of CD9 expression differs between tumour cells and stromal immune cells, and depends on the molecular subtype of the invasive breast carcinoma.

Kwon HJ, Choi JE, Kang SH, Son Y, Bae YK.

Histopathology. 2017 Jun;70(7):1155-1165. doi: 10.1111/his.13184. Epub 2017 Mar 27.

PMID:
28178752
3.

Invasive Pleomorphic Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients with Breast Cancer.

Sahin S, Karatas F, Erdem GU, Hacioglu B, Altundag K.

Am Surg. 2017 Apr 1;83(4):359-364.

PMID:
28424130
4.
5.

Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.

Adachi Y, Ishiguro J, Kotani H, Hisada T, Ichikawa M, Gondo N, Yoshimura A, Kondo N, Hattori M, Sawaki M, Fujita T, Kikumori T, Yatabe Y, Kodera Y, Iwata H.

BMC Cancer. 2016 Mar 25;16:248. doi: 10.1186/s12885-016-2275-4.

6.

Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast.

Rakha EA, El-Sayed ME, Menon S, Green AR, Lee AH, Ellis IO.

Breast Cancer Res Treat. 2008 Sep;111(1):121-7. Epub 2007 Oct 11.

PMID:
17929165
7.

Prognostic Value of Coexisting Lobular Carcinoma In Situ With Invasive Lobular Carcinoma.

Harbhajanka A, Lamzabi I, Syed S, Jain R, Ghai R, Reddy VB, Bitterman P, Gattuso P.

Appl Immunohistochem Mol Morphol. 2016 Nov/Dec;24(10):738-743.

PMID:
26574630
8.

[An analysis of 68 invasive lobular breast cancer cases in clinicopathological characteristics and the prognostic determinants].

Liu Q, Xiang HY, Ye JM, Xu L, Zhang H, Zhang S, Duan XN, Liu YH.

Zhonghua Wai Ke Za Zhi. 2018 Feb 1;56(2):119-123. doi: 10.3760/cma.j.issn.0529-5815.2018.02.008. Chinese.

PMID:
29397625
9.

Elevated Interleukin-13 Receptor Alpha 1 Expression in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Breast Cancer.

Park MH, Kwon HJ, Kim JR, Lee B, Lee SJ, Bae YK.

Ann Surg Oncol. 2017 Nov;24(12):3780-3787. doi: 10.1245/s10434-017-5907-2. Epub 2017 Jun 20.

PMID:
28634667
10.

Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.

Zengel B, Yararbas U, Duran A, Uslu A, Elıyatkın N, Demırkıran MA, Cengiz F, Şimşek C, Postacı H, Vardar E, Durusoy R.

Breast Cancer. 2015 Jul;22(4):374-81. doi: 10.1007/s12282-013-0489-8. Epub 2013 Aug 8.

PMID:
23925582
11.

Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.

Inoue M, Nakagomi H, Nakada H, Furuya K, Ikegame K, Watanabe H, Omata M, Oyama T.

Breast Cancer. 2017 Sep;24(5):667-672. doi: 10.1007/s12282-017-0753-4. Epub 2017 Jan 20.

PMID:
28108967
12.

Is invasive lobular carcinoma different from invasive ductal carcinoma?

Mersin H, Yildirim E, Gülben K, Berberoğlu U.

Eur J Surg Oncol. 2003 May;29(4):390-5.

PMID:
12711296
13.

Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.

García-Fernández A, Lain JM, Chabrera C, García Font M, Fraile M, Barco I, Torras M, Reñe A, González S, González C, Piqueras M, Veloso E, Cirera L, Pessarrodona A, Giménez N.

Breast J. 2015 Sep-Oct;21(5):533-7. doi: 10.1111/tbj.12455. Epub 2015 Jul 17.

PMID:
26190560
14.

[Lobular invasive breast cancer prognostic factors: About 940 patients].

Jauffret C, Houvenaeghel G, Classe JM, Garbay JR, Giard S, Charitansky H, Cohen M, Bélichard C, Faure C, Darai É, Hudry D, Azuar P, Villet R, Gimbergues P, Tunon de Lara C, Martino M, Coutant C, Dravet F, Chauvet MP, Chéreau Ewald E, Penault-Llorca F, Goncalves A, Lambaudie É.

Gynecol Obstet Fertil. 2015 Nov;43(11):712-7. doi: 10.1016/j.gyobfe.2015.09.007. Epub 2015 Oct 16. French.

PMID:
26482833
15.

Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma.

Park CK, Jung WH, Koo JS.

Breast Cancer Res Treat. 2016 Aug;159(1):55-69. doi: 10.1007/s10549-016-3929-2. Epub 2016 Jul 28.

PMID:
27469595
16.

Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.

Huan J, Gao Y, Xu J, Sheng W, Zhu W, Zhang S, Cao J, Ji J, Zhang L, Tian Y.

Int J Clin Exp Pathol. 2015 Mar 1;8(3):3054-61. eCollection 2015.

17.

Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.

Zhang M, Zhang X, Zhao S, Wang Y, Di W, Zhao G, Yang M, Zhang Q.

Target Oncol. 2014 Dec;9(4):349-57.

PMID:
24233638
18.

CD9 Expression in Colorectal Carcinomas and Its Prognostic Significance.

Kim KJ, Kwon HJ, Kim MC, Bae YK.

J Pathol Transl Med. 2016 Nov;50(6):459-468. Epub 2016 Oct 25.

19.

The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma.

Lai HW, Tseng LM, Chang TW, Kuo YL, Hsieh CM, Chen ST, Kuo SJ, Su CC, Chen DR.

Breast. 2013 Oct;22(5):968-73. doi: 10.1016/j.breast.2013.05.010. Epub 2013 Jun 17.

PMID:
23787124
20.

Immunohistochemical features of multifocal and multicentric lobular breast carcinoma.

Ilić IR, Petrović A, Živković VV, Randjelović PJ, Stojanović NM, Radulović NS, Randjelović D, Ilić RS.

Adv Med Sci. 2017 Mar;62(1):78-82. doi: 10.1016/j.advms.2016.07.003. Epub 2017 Feb 10.

PMID:
28189947

Supplemental Content

Support Center